Table 1.

Patient demographics and baseline characteristics for entire cohort (N = 83)

Characteristic
Age, yr
 Median60.0
 Min, Max23, 80
Sex, n (%)
 Male33 (39.8)
 Female50 (60.2)
Race, n (%)
 Asian1 (1.2)
 Black or African American6 (7.2)
 White75 (90.4)
 Other1 (1.2)
Ethnicity, n (%)
 Hispanic or Latino29 (34.9)
 Not Hispanic or Latino54 (65.1)
ECOG performance status, n (%)
 0–176 (91.6)
 27 (8.4)
Number of prior anticancer regimens
 Median4.0
 Min, Max1, 12
Tumor types, n (%)
 Breast21 (25.3)
 Colon18 (21.7)
 Lung8 (9.6)
 Rectal5 (6.0)
 Endometrial/uterine5 (6.0)
 Kidney3 (3.6)
 Pancreas3 (3.6)
 Ovary3 (3.6)
 Othera17 (20.5)
  • aOther tumor types included adrenal, neuroendocrine, gastric, prostate, testicular, esophageal, mesothelioma, cervical, bladder, sarcoma, small bowel, melanoma, and basal cell cancer.